@gently
I am aware of the history of these biomarkers and of course, the protocol before blood draw for a CTX test. But seems to me that a medical practitioner who is comfortable prescribing osteo treatment ought to stay abreast of acceptable monitoring procedures, given the side effects of any of these drugs and their cost.

Could not agree more about the diabetes epidemic's role in affecting the health care of the rest of us.....it is my experience about the difficulty of even getting an appointment with an endo.

If I was to try to convince a PCP to order biomarker tests, is there research and/or literature that could be the most persuasive? And who issues the 'standard care' about the use of bone markers?